A regression model to predict axillary high tumor burden in sentinel node-positive breast cancer patients

Affiliations

¹ Breast Unit, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
² University International of Catalunya, Barcelona, Spain.
³ Research Unit, Research Foundation Mútua Terrassa, Universitat de Barcelona, Barcelona, Spain.
⁴ Laboratory of Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
⁵ Nuclear Medicine Department, University Hospital of Mútua Terrassa, University of Barcelona, Spain.
⁶ Department of Hemato-oncology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
⁷ Breast Unit, Department of Gynecology, Hospital of Terrassa, Health Consortium of Terrassa, Spain.
⁸ Department of Nursing, Breastfeeding Consultant, Institut Català de la Salut, Barcelona, Spain.
⁹ Department of Pathology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
¹⁰ Department of Radiology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
¹¹ Department of Gynecology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
¹² Department of Nursing, School of Health Science TecnoCampus Mataró-Maresme, Mataró, Spain.

Israel Barco et al. Breast J. 2020 Feb.

. 2020 Feb;26(2):322-324.

doi: 10.1111/tbj.13594. Epub 2019 Sep 6.

¹ Breast Unit, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
² University International of Catalunya, Barcelona, Spain.
³ Research Unit, Research Foundation Mútua Terrassa, Universitat de Barcelona, Barcelona, Spain.
⁴ Laboratory of Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
⁵ Nuclear Medicine Department, University Hospital of Mútua Terrassa, University of Barcelona, Spain.
⁶ Department of Hemato-oncology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
⁷ Breast Unit, Department of Gynecology, Hospital of Terrassa, Health Consortium of Terrassa, Spain.
⁸ Department of Nursing, Breastfeeding Consultant, Institut Català de la Salut, Barcelona, Spain.
⁹ Department of Pathology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
¹⁰ Department of Radiology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
¹¹ Department of Gynecology, University Hospital of Mútua Terrassa, University of Barcelona, Barcelona, Spain.
¹² Department of Nursing, School of Health Science TecnoCampus Mataró-Maresme, Mataró, Spain.

No abstract available

References

1. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569-575.
1. Barco I, García Font M, García-Fernández A, et al. A logistic regression model predicting high axillary tumour burden in early breast cancer patients. Clin Transl Oncol. 2017;19:1393-1399.
1. García-Fernández A, Chabrera C, García-Font M, et al. Breast cancer patients undergoing sentinel node biopsy: additional axillary tumor burden as a function of the total number of excised sentinel nodes-a multicenter study. Clin Breast Cancer. 2015;15:490-497.
1. Bundred NJ, Barnes NL, Rutgers E, Donker M. Is axillary lymph node clearance required in node-positive breast cancer? Nat Rev Clin Oncol. 2015;12:55-61.
1. van la Parra RF, Peer PG, de Roos WK, Ernst MF, de Wilt JH, Bosscha K. A simple risk score to predict the presence of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node. World J Surg. 2014;38:1070-1076.